TD Cowen raised the firm’s price target on Agilon Health (AGL) to $17 from 60c and keeps a Hold rating on the shares. The firm updated its model to reflect its 1-for-25 reverse stock split.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGL:
- Agilon Health: Limited Upside and Profitability Uncertainty Support Hold Rating
- Agilon Health price target adjusted to $33 from $2 at Deutsche Bank
- Agilon Health price target adjusted to $16 at Evercore ISI after reverse split
- Why Is Vanguard Total Stock Market ETF (VTI) Falling Today, 4/7/2026?
- Why Is Vanguard Total Stock Market ETF (VTI) Up Today, 4/6/2026?